Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.
about
Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in MicemNos2 deletion and human NOS2 replacement in Alzheimer disease modelsA Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43.Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease.Active zone proteins are transported via distinct mechanisms regulated by Par-1 kinase.Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study.A case of 17q21.31 microduplication and 7q31.33 microdeletion, associated with developmental delay, microcephaly, and mild dysmorphic features.Modelling early responses to neurodegenerative mutations in mice.Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.Degradation of tau protein by autophagy and proteasomal pathways.MAPping out distribution routes for kinesin couriers.Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system.Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.Inflammatory changes in optic nerve after closed-head repeated traumatic brain injury: Preliminary study.NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.Modulating the microtubule-tau interactions in biomotility systems by altering the chemical environment.Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
P2860
Q27334314-A611CEAC-6990-4BD1-ABF1-7A0CFBA71420Q34041402-7989516B-BDAB-4F96-84F2-C6F97F3A5D36Q34882752-086011FF-4142-4D75-839E-B75420AF000FQ36060128-D46ACA0D-97E8-41EE-B884-7DE6A985E2F4Q36286130-7C9CD410-0330-4289-B03A-E902AA657A4BQ37107652-D50FFD1A-2814-43F1-A869-B12748019496Q37598586-9BB42BBB-2F22-488E-8E72-48AAC330F5C1Q37905130-9AEC5548-FD3D-45EE-8060-270F75B16168Q37957147-7D31CD5B-1226-4148-A102-7B88D0A43035Q38027933-D4023236-F958-414C-9B20-BC6B2AC3B81CQ38116595-B3831C4C-B70A-4CBA-A04B-6B31F573C0BAQ38925223-3FEE994C-7213-4339-8287-19451F02B8EEQ41966030-C17A3DA6-9DB6-4A49-8935-62577D2439D7Q47366484-F4A494BD-9E7A-4FBC-B88B-EE6A2C854EFCQ47950496-E47FE959-B7CA-46C5-87D2-65965B9D0AA1Q48959559-899184AF-E0EA-4C9B-85B2-F18441D6D2AEQ50860536-9E0EC8EF-C7DC-48F8-8AC8-E389844F4A11Q51118986-066AD35B-AD9D-4B1F-8628-0305FAE14CFCQ53397873-DF1119A9-A3C0-4AED-A272-225292125C29
P2860
Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@en
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@nl
type
label
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@en
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@nl
prefLabel
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@en
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@nl
P2093
P2860
P1476
Overexpression of wild-type mu ...... uopathy and neurodegeneration.
@en
P2093
Amy E Innes
Eileen McGowan
Melinda McBride
Michael Deture
Mike Hutton
Richard J P Crook
Stephanie J Adams
Suzanne J Randle
Wen-Lang Lin
P2860
P304
P356
10.2353/AJPATH.2009.090462
P407
P577
2009-08-28T00:00:00Z